... in regional cerebral blood flow associated with a 45day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer s disease: results of a randomized, double blinded, pilot study . Exp Gerontol 2018 111 : 118 21 . 13. Kelly DF , Martin NA , Kordestani...